Vanguard Capital Management’s Citius Pharmaceuticals CTXR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$141K Buy
264,672
+67,308
+34% +$39.7K ﹤0.01% 3815
2026
Q2
$119K Buy
197,364
+29,626
+18% +$20.1K ﹤0.01% 3865
2026
Q1
$151K Buy
+167,738
New +$135K ﹤0.01% 3827

Other funds holding CTXR

Vanguard Capital Management's CTXR Position: Q3 2026 in Review

Vanguard Capital Management increased its Citius Pharmaceuticals (CTXR) stake by 34% in Q3 2026, buying an estimated $39.7K and bringing the position to 264,672 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #3815.

Vanguard Capital Management first reported a position in CTXR in Q1 2026 and has held it in 3 quarters since. The position peaked at $151K in Q1 2026. 34 funds tracked by Wall St. Rank hold CTXR as of Q3 2026.

  • Vanguard Capital Management held 264,672 shares of Citius Pharmaceuticals worth $141K as of Q3 2026.
  • Vanguard Capital Management bought 67,308 Citius Pharmaceuticals shares in Q3 2026, an estimated $39.7K.
  • Citius Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3815 holding.
  • Vanguard Capital Management first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Citius Pharmaceuticals position peaked at $151K in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.